-
1
-
-
0033807776
-
Liver transplantation for autoimmune hepatitis
-
Reich DJ, Fiel I, Guarrera JV et al. Liver transplantation for autoimmune hepatitis. Hepatology 2000; 32: 693-700.
-
(2000)
Hepatology
, vol.32
, pp. 693-700
-
-
Reich, D.J.1
Fiel, I.2
Guarrera, J.V.3
-
2
-
-
0343415072
-
Monitoring azathioprine therapy in pediatric renal transplant patients with red blood cell thiopurine methyltransferase
-
Dervieux T, Medard Y, Baudouin V et al. Monitoring azathioprine therapy in pediatric renal transplant patients with red blood cell thiopurine methyltransferase. Transplant Proc 2000; 32: 361-363.
-
(2000)
Transplant Proc
, vol.32
, pp. 361-363
-
-
Dervieux, T.1
Medard, Y.2
Baudouin, V.3
-
3
-
-
0023588197
-
Assay of 6-thiosinic acid and 6-thioguanine nucleotides, active metabolites of of 6-mercaptopurine, in human red blood cells
-
Lennard L. Assay of 6-thiosinic acid and 6-thioguanine nucleotides, active metabolites of of 6-mercaptopurine, in human red blood cells. J Chromatogr 1987; 423: 169-178.
-
(1987)
J Chromatogr
, vol.423
, pp. 169-178
-
-
Lennard, L.1
-
5
-
-
0025757370
-
Azathioprine hepatotoxicity after liver transplanation
-
Sterneck M, Wiesner R, Ascher N et al. Azathioprine hepatotoxicity after liver transplanation. Hepatology 1991; 14: 806-810.
-
(1991)
Hepatology
, vol.14
, pp. 806-810
-
-
Sterneck, M.1
Wiesner, R.2
Ascher, N.3
-
6
-
-
0024510347
-
Hepatotoxicity of azathioprine in renal transplant recipients
-
Ramalho HJ, Terra EG, Cartapatti E et al. Hepatotoxicity of azathioprine in renal transplant recipients. Transplant Proc 1989; 21: 1716-1717.
-
(1989)
Transplant Proc
, vol.21
, pp. 1716-1717
-
-
Ramalho, H.J.1
Terra, E.G.2
Cartapatti, E.3
-
7
-
-
0025736095
-
Reversible cholestasis with bile duct injury following azathioprine therapy. A case report
-
Horsmans Y, Rahier J, Geubel AP. Reversible cholestasis with bile duct injury following azathioprine therapy. A case report. Liver 1991; 11: 89-93.
-
(1991)
Liver
, vol.11
, pp. 89-93
-
-
Horsmans, Y.1
Rahier, J.2
Geubel, A.P.3
-
8
-
-
0019799332
-
A method for estimating the probability of adverse drug reactions
-
Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245.
-
(1981)
Clin Pharmacol Ther
, vol.30
, pp. 239-245
-
-
Naranjo, C.A.1
Busto, U.2
Sellers, E.M.3
-
9
-
-
0018822866
-
Mercaptopurine pharmacogenetics: Monogenic inheritance of erythrocyte thiopurine methyltransferase activity
-
Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: Monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980; 32: 651-662.
-
(1980)
Am J Hum Genet
, vol.32
, pp. 651-662
-
-
Weinshilboum, R.M.1
Sladek, S.L.2
-
10
-
-
0034067784
-
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
-
Dubinsky MC, Lamothe S, Yang HY et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000; 118: 705-713.
-
(2000)
Gastroenterology
, vol.118
, pp. 705-713
-
-
Dubinsky, M.C.1
Lamothe, S.2
Yang, H.Y.3
-
11
-
-
0036202803
-
6-MP metabolite profiles provide a biochemical explanation for 6MP resistance in patients with inflammatory bowel disease
-
Dubinsky MC, Yang H, Hassard PV et al. 6-MP metabolite profiles provide a biochemical explanation for 6MP resistance in patients with inflammatory bowel disease. Gastroenterology 2002; 122: 904-915.
-
(2002)
Gastroenterology
, vol.122
, pp. 904-915
-
-
Dubinsky, M.C.1
Yang, H.2
Hassard, P.V.3
-
12
-
-
0026758498
-
The clinical pharmacology of 6-mercaptopurine
-
Lennard L. The clinical pharmacology of 6-mercaptopurine. Eur J Clin Pharm 1992; 43: 329-339.
-
(1992)
Eur J Clin Pharm
, vol.43
, pp. 329-339
-
-
Lennard, L.1
-
13
-
-
0037237923
-
Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD
-
Seidman EG. Clinical Use and Practical Application of TPMT Enzyme and 6-Mercaptopurine Metabolite Monitoring in IBD. Rev Gastroenterol Disord 2003; 3: S30-S38.
-
(2003)
Rev Gastroenterol Disord
, vol.3
-
-
Seidman, E.G.1
-
14
-
-
0035037706
-
Utilization of erythrocyte 6-thioguanine metabolite levels to optimize azathioprine therapy in patients with inflammatory bowel disease
-
Cuffari C, Hunt S, Bayless T. Utilization of erythrocyte 6-thioguanine metabolite levels to optimize azathioprine therapy in patients with inflammatory bowel disease. Gut 2001; 48: 642-646.
-
(2001)
Gut
, vol.48
, pp. 642-646
-
-
Cuffari, C.1
Hunt, S.2
Bayless, T.3
-
15
-
-
0141957449
-
Determination of thiopurine methyltransferase phenotype in isolated human erythrocytes using a new simple nonradioactive HPLC method
-
Indjova D, Shipkova M, Atanasova S et al. Determination of thiopurine methyltransferase phenotype in isolated human erythrocytes using a new simple nonradioactive HPLC method. Ther Drug Monit 2003; 25: 637-644.
-
(2003)
Ther Drug Monit
, vol.25
, pp. 637-644
-
-
Indjova, D.1
Shipkova, M.2
Atanasova, S.3
-
16
-
-
0036736440
-
Azathioprine metabolite measurements in the treatment of autoimmune hepatitis in pediatric patients: A preliminary report
-
Rumbo C, Emerick KM, Emre S, Schneider BL. Azathioprine metabolite measurements in the treatment of autoimmune hepatitis in pediatric patients: a preliminary report. J Pediatr Gastroenterol Nutr 2002; 35: 391-398.
-
(2002)
J Pediatr Gastroenterol Nutr
, vol.35
, pp. 391-398
-
-
Rumbo, C.1
Emerick, K.M.2
Emre, S.3
Schneider, B.L.4
|